Anticoagulation-related intracranial hemorrhage - Henry Ford Health ...

EBM for use of PCC
Sandler SG, Rath CE, Ruder A. Prothrombin complex concentrates Yasaka M, Oomura M, Ikeno K, Naritomi H, Minematsu K.
in acquired hypoprothrombinemia. Ann Intern Med.
Effect of prothrombin complex concentrate on INR and blood
1973;79(4):485–91.
coagulation system in emergency patients treated with warfarin
Josic D, Hoffer L, Buchacher A, Schwinn H, Frenzel W, Biesert L,
overdose. Ann Hematol. 2003;82(2):121–3.
et al. Manufacturing of a prothrombin complex concentrate aiming
van Aart L, Eijkhout HW, Kamphuis JS, Dam M, Schattenkerk
at low thrombogenicity. Thromb Res. 2000;100(5):433–41.
ME, Schouten TJ, et al. Individualized dosing regimen for
Hellstern P. Production and composition of prothrombin complex
prothrombin
concentrates: correlation between composition and therapeutic
complex concentrate more effective than standard
efficiency. Thromb Res. 1999;95(4 Suppl 1):S7–12.
treatment in the reversal of oral anticoagulant therapy: an open,
McQuillan AM, Eikelboom JW, Hankey GJ, Baker R, Thom J,
Staton J, et al. Protein Z in ischemic stroke and its etiologic
subtypes. Stroke. 2003;34(10):2415–9.
Lubetsky A, Hoffman R, Zimlichman R, Eldor A, Zvi J, Kostenko
V, et al. Efficacy and safety of a prothrombin complex
concentrate (Octaplex) for rapid reversal of oral anticoagulation.
Thromb Res. 2004;113(6):371–8.
Evans G, Luddington R, Baglin T. Beriplex P/N reverses severe
warfarin-induced overanticoagulation immediately and completely
in patients presenting with major bleeding. Br J Haematol.
2001;115(4):998–1001.
Ostermann H, Haertel S, Knaub S, Kalina U, Jung K, Pabinger I.
Pharmacokinetics of Beriplex P/N prothrombin complex concentrate
in healthy volunteers. Thromb Haemost. 2007;98(4):
790–7.
Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX
complex in warfarin-related intracranial hemorrhage. Neurosurgery.
1999;45(5):1113–8. discussion 1118–1119.
Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex
concentrate for oral anticoagulant reversal in neurosurgical
emergencies. Br J Neurosurg. 2000;14(5):458–61.
Fredriksson K, Norrving B, Stromblad LG. Emergency reversal
of anticoagulation after intracerebral hemorrhage. Stroke. 1992;
23(7):972–7.
Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM.
Urgent reversal of warfarin with prothrombin complex concentrate.
J Thromb Haemost. 2006;4(5):967–70.
Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann
H. Prothrombin complex concentrate (Beriplex P/N) for
emergency anticoagulation reversal: a prospective multinational
clinical trial. J Thromb Haemost. 2008;6(4):622–31.
Preston FE, Laidlaw ST, Sampson B, Kitchen S. Rapid reversal
of oral anticoagulation with warfarin by a prothrombin complex
concentrate (Beriplex): efficacy and safety in 42 patients. Br J
Haematol. 2002;116(3):619–24.
Vigue B, Ract C, Tremey B, Engrand N, Leblanc PE, Decaux A,
prospective randomized d controlled trial. Thromb Res. 2006;
118(3):313–20.
Bruce D, Nokes TJ. Prothrombin complex concentrate (Beriplex
P/N) in severe bleeding: experience in a large tertiary hospital.
Crit Care. 2008;12(4):R105.
Yasaka M, Sakata T, Naritomi H, Minematsu K. Optimal dose of
prothrombin complex concentrate for acute reversal of oral
anticoagulation. Thromb Res. 2005;115(6):455–9.
Hellstern P, Halbmayer WM, Kohler M, Seitz R, Muller-Berghaus
G. Prothrombin complex concentrates: indications, contraindications,
and risks: a task force summary. Thromb Res. 1999;95(4
Suppl 1):S3–6.
Schulman S, Bijsterveld NR. Anticoagulants and their reversal.
Transfus Med Rev. 2007;21(1):37–48.
50. Pindur G, Morsdorf S. The use of prothrombin complex
concentrates
in the treatment of hemorrhages induced by oral
anticoagulation. Thromb Res. 1999;95(4 Suppl 1):S57–61.
Makris M, Watson HG. The management of coumarin-induced
over-anticoagulation Annotation. Br J Haematol. 2001;114(2):
271–80.
Crawford JH, Augustson BM. Prothrombinex use for the reversal
of warfarin: is fresh frozen plasma needed? Med J Aust. 2006;
184(7):365–6.
Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston
MA, Sarode R. Suboptimal effect of a three-factor prothrombin
complex concentrate (Profilnine-SD) in correcting supratherapeutic
international normalized ratio due to warfarin overdose.
Transfusion. 2009;49(6):1171–7.
Blatt PM, Lundblad RL, Kingdon HS, McLean G, Roberts HR.
Thrombogenic materials in prothrombin complex concentrates.
Ann Intern Med. 1974;81(6):766–70.
5/9/2012 40
et al. Ultra-rapid management of oral anticoagulant therapyrelated
surgical intracranial hemorrhage. Intensive Care Med.
2007;33(4):721–5.
55. Schimpf K, Zeltsch C, Zeltsch P. Myocardial infarction
complicating
activated prothrombin complex concentrate substitution in
patient with hemophilia A. Lancet. 1982;2(8306):1043.
Hampton KK, Preston FE, Lowe GD, Walker ID, Sampson B.
Reduced coagulation activation following infusion of a highly
purified factor IX concentrate compared to a prothrombin complex
concentrate. Br J Haematol. 1993;84(2):279–84.
57. Aledort LM. Factor IX and thrombosis. Scand J Haematol Suppl.